ASSC Genetics summit

The Australian Skin and Skin Cancer Research Centre (ASSC) is hosting the Genetics Summit, on 21 March, 2022, at the Translational Research Institute. This meeting in Brisbane will bring together multiple stakeholder groups (including researchers, NGOs, government agencies, specialist colleges, clinicians, and consumers) to review the latest evidence in this debate. 

Inherited variation at multiple genes plays a major role in determining who develops cutaneous melanoma, and the risk from these genes can be combined as a polygenic risk score. The use of polygenic risk scores in chronic diseases and cancers is a rapidly evolving field, and questions remain about their potential value in disease prediction and management. Generating a consensus roadmap that outlines the role for polygenic risk scores in melanoma management is challenging yet critical.

Find out more and register here >> ASSC Genetics Summit